Magnitude and laterality of breast cancer risk according to histologic type of atypical hyperplasia: Results from the nurses' health study

Cancer

Volumn 109, Issue 2, 2007, Pages 180-187

  Collins, Laura C ^a,e   Baer, Heather J ^b,c   Tamimi, Rulla M ^b,c   Connolly, James L ^a   Colditz, Graham A ^b,c,d   Schnitt, Stuart J ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^d HARVARD CENTER FOR CANCER PREVENTION   (United States)

^e BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

Atypical ductal hyperplasia; Atypical hyperplasia; Atypical lobular hyperplasia; Breast cancer

Indexed keywords

TUMOR MARKER;

ADOLESCENT; ADULT; AGED; BREAST BIOPSY; BREAST CANCER; BREAST HYPERPLASIA; CANCER INVASION; CANCER PATIENT; CANCER RISK; CONTROLLED STUDY; FEMALE; HIGH RISK PATIENT; HISTOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; PREMENOPAUSE; PRIORITY JOURNAL; REVIEW;

ADOLESCENT; ADULT; AGED; BIOPSY; BREAST; BREAST NEOPLASMS; HUMANS; HYPERPLASIA; MIDDLE AGED; ODDS RATIO; RISK FACTORS;

EID: 33846245493     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.22408     Document Type: Review

References (26)

1. Kodlin D, Winger EE, Morgenstern NL, Chen U. Chronic mastopathy and breast cancer. A follow-up study. Cancer. 1977;39:2603-2607.
2. Dupont WD, Page DL. Risk factors for breast cancer in women with proliferative breast disease. N Engl J Med. 1985; 312:146-151.
3. Carter CL, Corle DK, Micozzi MS, Schatzkin A, Taylor PR. A prospective study of the development of breast cancer in 16,692 women with benign breast disease. Am J Epidemiol. 1988;128:467-477.
4. Tavassoli FA, Norris HJ. A comparison of the results of long-term follow-up for atypical intraductal hyperplasia and intraductal hyperplasia of the breast. Cancer. 1990;65: 518-529.
5. Palli D, Rosselli del Turco M, Simoncini R, Bianchi S. Benign breast disease and breast cancer: a case-control study in a cohort in Italy. Int J Cancer. 1991;47:703-706.
6. London SJ, Connolly JL, Schnitt SJ, Colditz GA. A prospective study of benign breast disease and the risk of breast cancer. JAMA. 1992;267:941-944.
7. Krieger N, Hiatt RA. Risk of breast cancer after benign breast diseases. Variation by histologic type, degree of atypia, age at biopsy, and length of follow-up. Am J Epidemiol. 1992;135:619-631.
8. McDivitt RW, Stevens JA, Lee NC, Wingo PA, Rubin GL, Gersell D. Histologic types of benign breast disease and the risk for breast cancer. The Cancer and Steroid Hormone Study Group. Cancer. 1992;69:1408-1414.
9. Dupont WD, Parl FF, Hartmann WH, et al. Breast cancer risk associated with proliferative breast disease and atypical hyperplasia. Cancer. 1993;71:1258-1265.
10. Bodian CA, Perzin KH, Lattes R, Hoffmann P, Abernathy TG. Prognostic significance of benign proliferative breast disease. Cancer. 1993;71:3896-3907.
11. Marshall LM, Hunter DJ, Connolly JL, et al. Risk of breast cancer associated with atypical hyperplasia of lobular and ductal types. Cancer Epidemiol Biomarkers Prev. 1997;6: 297-301.
12. Shaaban AM, Sloane JP, West CR, et al. Histopathologic types of benign breast lesions and the risk of breast cancer: case-control study. Am J Surg Pathol. 2002;26:421-430.
13. Hartmann LC, Sellers TA, Frost MH, et al. Benign breast disease and the risk of breast cancer. N Engl J Med. 2005;353:229-237.
14. Fitzgibbons PL, Henson DE, Hutter RV. Benign breast changes and the risk for subsequent breast cancer: an update of the 1985 consensus statement. Cancer Committee of the College of American Pathologists. Arch Pathol Lab Med. 1998;122:1053-1-55.
15. Page DL, Dupont WD, Rogers LW, Rados MS. Atypical hyperplastic lesions of the female breast. A long-term follow-up study. Cancer. 1985;55:2698-2708.
16. Dupont WD, Page DL. Relative risk of breast cancer varies with time since diagnosis of atypical hyperplasia. Hum Pathol. 1989;20:723-725.
17. Rubin E, Visscher DW, Alexander RW, Urist MM, Maddox WA. Proliferative disease and atypia in biopsies performed for nonpalpable lesions detected mammographically. Cancer. 1988;61:2077-2082.
18. Liberman L, Cohen MA, Dershaw DD, Abramson AF, Hann LE, Rosen PP. Atypical ductal hyperplasia diagnosed at stereotaxic core biopsy of breast lesions: an indication for surgical biopsy [see comments]. AJR Am J Roentgenol. 1995;164: 1111-1113.
19. Ioffe OB, Berg WA, Silverberg SG, Kumar D. Mammographic-histopathologic correlation of large-core needle biopsies of the breast. Mod Pathol. 1998;11:721-727.
20. Stampfer MJ, Willett WC, Speizer FE, et al. Test of the National Death Index. Am J Epidemiol. 1984;119:837-839.
21. Colditz GA. The Nurses' Health Study: findings during 10 years of follow-up of a cohort of U.S. women. Curr Probl Obstet Gynecol Fertil. 1990;13:129-174.
22. Page DL, Dupont WD, Rogers LW. Ductal involvement by cells of atypical lobular hyperplasia in the breast: a long-term follow-up study of cancer risk. Hum Pathol. 1988;19: 201-207.
23. Page DL, Schuyler PA, Dupont WD, Jensen RA, Plummer WD Jr, Simpson JF. Atypical lobular hyperplasia as a unilateral predictor of breast cancer risk: a retrospective cohort study. Lancet. 2003;361:125-129.
24. Leonard GD, Swain SM. Ductal carcinoma in situ, complexities and challenges. J Natl Cancer Inst. 2004;96:906-920.
25. Burstein HJ, Polyak K, Wong JS, Lester SC, Kaelin CM. Ductal carcinoma in situ of the breast. N Engl J Med. 2004;350: 1430-1441.
26. Erbas B, Provenzano E, Armes J, Gertig D. The natural history of ductal carcinoma in situ of the breast: a review. Breast Cancer Res Treat. 2006;97:135-144.